About Hope
Your location :
Home
 / About Hope
/
Milestones

Milestones

  • Now

    • National High-tech Enterprise Awarded for 15 consecutive years • Top 20 Chinese Pharmaceutical R&D Companies Awarded for three consecutive years • 30+ Invention Patents Applied • 70+ clinical & Production & New Drug Certifications Approved • 10+ International Registration (EU, FDA, etc. ) Submitted • 100+ Technology Transfer Finished • 20+ Series products commercialized
  • 2020

    • Jinghai Industrial Park R&D Center Operated • Strategic Partnership with Zezheng Pharmaceutical Established
  • 2019

    • Subsidiary HMYA Established, International Business Operated Independently • EU & FDA Application Submitted • Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected) • CSAIII Pilot • T100 New Technology & New Product Innovation Action Outstanding Enterprise Awarded
  • 2018

    • Strategic Partnership with PPC Group Established • Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)
  • 2017

    • Strategic Partnership with Porton Pharmaceutical Established • Top 20 Chinese Pharmaceutical R&D Companies Awarded
  • 2016

    • Subsidiary HMY Established, CRO Business Operated Independently
  • 2015

    • Subsidiary HMT Established, The Raw Materials & Intermediates Business Operated Independently • Employee Stock Ownership Platform Established, Shareholding Reform Finished
  • 2013

    • The First Patent Certificate Awarded
  • 2012

    • The First New Drug Certificate Acquired • Technology R & D Institution (Beijing) Awarded • Audited by Foreign Clients
  • 2011

    • Equity Investment in Shandong Confucius Pharmaceutical
  • 2008

    • Strategic Partnership with Peking Chemical Heng-ye Established
  • 2007

    • National High-tech Enterprise Awarded
  • 2006

    • New Drug R & D Center Established
  • 2005

    • Hope Pharmaceutical Founded

  

Beijing Hope Pharmaceutical Co., Ltd.   京ICP备17065299号

这是描述信息